FDA Approves Leucovorin—But Not For Autism, Even After Trump Admin Officials Touted Drug Last Year

The Food and Drug Administration approved the drug leucovorin as a treatment for the rare genetic condition cerebral ​folate deficiency on Tuesday—but stopped short of approving it as a treatment for autism in general, an abrupt shift after members of the administration previously mentioned it as a potential therapy for the developmental disorder.